Y-mAbs Therapeutics, Inc.

DEUTSCHE BANK AG\

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/12/2025

Shares

28,803

Value ($000)

130

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/12/2025	130	0.0%	28,803	6/30/2025
2025 Q1	5/9/2025	128	0.0%	28,803	3/31/2025
2024 Q4	6/30/2025	253	0.0%	32,253	12/31/2024
2024 Q3	6/26/2025	279	0.0%	21,194	9/30/2024
2024 Q2	6/12/2025	272	0.0%	22,536	6/30/2024
2024 Q1	6/2/2025	303	0.0%	18,639	3/31/2024
2023 Q4	2/14/2024	127	0.0%	18,664	12/31/2023
2023 Q3	11/24/2023	99	0.0%	18,155	9/30/2023
2023 Q2	8/14/2023	123	0.0%	18,155	6/30/2023
2023 Q1	5/15/2023	118	0.0%	23,623	3/31/2023
2022 Q4	2/13/2023	85	0.0%	17,432	12/31/2022
2022 Q3	11/14/2022	248	0.0%	17,186	9/30/2022
2022 Q2	8/11/2022	1,064	0.0%	70,336	6/30/2022
2022 Q1	5/13/2022	3,624	0.0%	305,042	3/31/2022
2021 Q4	2/16/2022	396	0.0%	24,402	12/31/2021
2021 Q3	11/4/2021	653	0.0%	22,857	9/30/2021
2021 Q2	8/11/2021	946	0.0%	27,999	6/30/2021
2021 Q1	5/13/2021	806	0.0%	26,670	3/31/2021
2020 Q4	2/16/2021	1,432	0.0%	28,921	12/31/2020
2020 Q3	11/12/2020	853	0.0%	22,214	9/30/2020
2020 Q2	8/13/2020	1,178	0.0%	27,275	6/30/2020
2020 Q1	5/14/2020	1,425	0.0%	54,589	3/31/2020
2019 Q4	2/14/2020	5,037	0.0%	161,249	12/31/2019